JP2008509982A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008509982A5 JP2008509982A5 JP2007526578A JP2007526578A JP2008509982A5 JP 2008509982 A5 JP2008509982 A5 JP 2008509982A5 JP 2007526578 A JP2007526578 A JP 2007526578A JP 2007526578 A JP2007526578 A JP 2007526578A JP 2008509982 A5 JP2008509982 A5 JP 2008509982A5
- Authority
- JP
- Japan
- Prior art keywords
- urea
- ureido
- ylphenyl
- benzoic acid
- fluorophenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000000217 alkyl group Chemical group 0.000 claims 22
- 125000003545 alkoxy group Chemical group 0.000 claims 17
- 150000001875 compounds Chemical class 0.000 claims 17
- 229910052739 hydrogen Inorganic materials 0.000 claims 13
- 239000001257 hydrogen Substances 0.000 claims 13
- 239000004202 carbamide Substances 0.000 claims 10
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea group Chemical group NC(=O)N XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 10
- 150000002431 hydrogen Chemical class 0.000 claims 9
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 8
- 125000001153 fluoro group Chemical group F* 0.000 claims 8
- 229910052736 halogen Inorganic materials 0.000 claims 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 8
- 125000001072 heteroaryl group Chemical group 0.000 claims 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 7
- 125000002619 bicyclic group Chemical group 0.000 claims 6
- 150000002367 halogens Chemical class 0.000 claims 6
- 125000004450 alkenylene group Chemical group 0.000 claims 5
- 125000002947 alkylene group Chemical group 0.000 claims 5
- 125000001309 chloro group Chemical group Cl* 0.000 claims 5
- 201000010099 disease Diseases 0.000 claims 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 5
- 125000004428 fluoroalkoxy group Chemical group 0.000 claims 5
- 125000000623 heterocyclic group Chemical group 0.000 claims 5
- -1 oxaazepan-4-ylphenyl Chemical group 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims 4
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 4
- 125000003709 fluoroalkyl group Chemical group 0.000 claims 4
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 4
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 3
- 125000001313 C5-C10 heteroaryl group Chemical group 0.000 claims 2
- 208000008589 Obesity Diseases 0.000 claims 2
- 150000001412 amines Chemical class 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 claims 2
- 208000010877 cognitive disease Diseases 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 125000005842 heteroatom Chemical group 0.000 claims 2
- 239000012948 isocyanate Substances 0.000 claims 2
- 150000002513 isocyanates Chemical class 0.000 claims 2
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 claims 2
- 150000002825 nitriles Chemical class 0.000 claims 2
- 235000020824 obesity Nutrition 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- JUXJZTJLUULZRU-UHFFFAOYSA-N 1,3-bis(4-acetylphenyl)urea Chemical compound C1=CC(C(=O)C)=CC=C1NC(=O)NC1=CC=C(C(C)=O)C=C1 JUXJZTJLUULZRU-UHFFFAOYSA-N 0.000 claims 1
- NLNLEHOVZAHYIG-UHFFFAOYSA-N 1-(1,3-benzodioxol-5-yl)-3-(3-fluoro-4-piperidin-1-ylphenyl)urea Chemical compound FC1=CC(NC(=O)NC=2C=C3OCOC3=CC=2)=CC=C1N1CCCCC1 NLNLEHOVZAHYIG-UHFFFAOYSA-N 0.000 claims 1
- BFRUERPRKIZNKB-UHFFFAOYSA-N 1-(1,3-benzothiazol-6-yl)-3-(4-fluorophenyl)urea Chemical compound C1=CC(F)=CC=C1NC(=O)NC1=CC=C(N=CS2)C2=C1 BFRUERPRKIZNKB-UHFFFAOYSA-N 0.000 claims 1
- UIXCITLDYZBUBG-UHFFFAOYSA-N 1-(1-benzothiophen-2-yl)-3-(2-methylphenyl)urea Chemical compound CC1=CC=CC=C1NC(=O)NC1=CC2=CC=CC=C2S1 UIXCITLDYZBUBG-UHFFFAOYSA-N 0.000 claims 1
- JVBRQEDQTAWFSZ-UHFFFAOYSA-N 1-(1-benzothiophen-2-yl)-3-(4-methylsulfonylphenyl)urea Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC(=O)NC1=CC2=CC=CC=C2S1 JVBRQEDQTAWFSZ-UHFFFAOYSA-N 0.000 claims 1
- IYQRIUDYNWXIGO-UHFFFAOYSA-N 1-(1-methylindazol-5-yl)-3-[4-(morpholin-4-ylmethyl)phenyl]urea Chemical compound C=1C=C2N(C)N=CC2=CC=1NC(=O)NC(C=C1)=CC=C1CN1CCOCC1 IYQRIUDYNWXIGO-UHFFFAOYSA-N 0.000 claims 1
- GYMHJBJSCBQERO-UHFFFAOYSA-N 1-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(3-fluoro-4-piperidin-1-ylphenyl)urea Chemical compound FC1=CC(NC(=O)NC=2C=C3OCCOC3=CC=2)=CC=C1N1CCCCC1 GYMHJBJSCBQERO-UHFFFAOYSA-N 0.000 claims 1
- DEJJUOYQOWMNEH-UHFFFAOYSA-N 1-(2,3-dihydro-1-benzofuran-6-yl)-3-(3-fluoro-4-piperidin-1-ylphenyl)urea Chemical compound FC1=CC(NC(=O)NC=2C=C3OCCC3=CC=2)=CC=C1N1CCCCC1 DEJJUOYQOWMNEH-UHFFFAOYSA-N 0.000 claims 1
- RENAWGQIHCWXQF-UHFFFAOYSA-N 1-(2-fluorophenyl)-3-(4-fluorophenyl)urea Chemical compound C1=CC(F)=CC=C1NC(=O)NC1=CC=CC=C1F RENAWGQIHCWXQF-UHFFFAOYSA-N 0.000 claims 1
- TWMYLEWQSBWPQU-UHFFFAOYSA-N 1-(2-thiophen-2-ylethyl)-3-[4-(trifluoromethoxy)phenyl]urea Chemical compound C1=CC(OC(F)(F)F)=CC=C1NC(=O)NCCC1=CC=CS1 TWMYLEWQSBWPQU-UHFFFAOYSA-N 0.000 claims 1
- XYQFVUJLUJPCQW-UHFFFAOYSA-N 1-(2-thiophen-2-ylethyl)-3-[4-(trifluoromethyl)phenyl]urea Chemical compound C1=CC(C(F)(F)F)=CC=C1NC(=O)NCCC1=CC=CS1 XYQFVUJLUJPCQW-UHFFFAOYSA-N 0.000 claims 1
- ORUYFSZLJGWGPX-UHFFFAOYSA-N 1-(3,4-dichlorophenyl)-3-(3-fluoro-4-piperidin-1-ylphenyl)urea Chemical compound C=1C=C(N2CCCCC2)C(F)=CC=1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ORUYFSZLJGWGPX-UHFFFAOYSA-N 0.000 claims 1
- QHESGFXHFNJGKU-UHFFFAOYSA-N 1-(3,5-dichlorophenyl)-3-(3-fluoro-4-piperidin-1-ylphenyl)urea Chemical compound C=1C=C(N2CCCCC2)C(F)=CC=1NC(=O)NC1=CC(Cl)=CC(Cl)=C1 QHESGFXHFNJGKU-UHFFFAOYSA-N 0.000 claims 1
- VVURLSLLFBZPPD-UHFFFAOYSA-N 1-(3,5-dimethoxyphenyl)-3-(3-fluoro-4-piperidin-1-ylphenyl)urea Chemical compound COC1=CC(OC)=CC(NC(=O)NC=2C=C(F)C(N3CCCCC3)=CC=2)=C1 VVURLSLLFBZPPD-UHFFFAOYSA-N 0.000 claims 1
- CGCYEPPBGPPQQH-UHFFFAOYSA-N 1-(3-acetylphenyl)-3-[2-(4-chlorophenyl)ethyl]urea Chemical compound CC(=O)C1=CC=CC(NC(=O)NCCC=2C=CC(Cl)=CC=2)=C1 CGCYEPPBGPPQQH-UHFFFAOYSA-N 0.000 claims 1
- XGBFOAJXGNRYMC-UHFFFAOYSA-N 1-(3-chloro-4-fluorophenyl)-3-(3-fluoro-4-piperidin-1-ylphenyl)urea Chemical compound C1=C(Cl)C(F)=CC=C1NC(=O)NC(C=C1F)=CC=C1N1CCCCC1 XGBFOAJXGNRYMC-UHFFFAOYSA-N 0.000 claims 1
- JUZGHGIUMRWRST-UHFFFAOYSA-N 1-(3-chloro-4-morpholin-4-ylphenyl)-3-(4-chlorophenyl)urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC(C=C1Cl)=CC=C1N1CCOCC1 JUZGHGIUMRWRST-UHFFFAOYSA-N 0.000 claims 1
- UJHMVWFXDGNNAD-UHFFFAOYSA-N 1-(3-chlorophenyl)-3-(2-thiophen-2-ylethyl)urea Chemical compound ClC1=CC=CC(NC(=O)NCCC=2SC=CC=2)=C1 UJHMVWFXDGNNAD-UHFFFAOYSA-N 0.000 claims 1
- XAFLXKOKDVXRMQ-UHFFFAOYSA-N 1-(3-chlorophenyl)-3-(3-fluoro-4-piperidin-1-ylphenyl)urea Chemical compound C=1C=C(N2CCCCC2)C(F)=CC=1NC(=O)NC1=CC=CC(Cl)=C1 XAFLXKOKDVXRMQ-UHFFFAOYSA-N 0.000 claims 1
- RNCJYUXWPOFCKE-UHFFFAOYSA-N 1-(3-chlorophenyl)-3-(4-ethoxyphenyl)urea Chemical compound C1=CC(OCC)=CC=C1NC(=O)NC1=CC=CC(Cl)=C1 RNCJYUXWPOFCKE-UHFFFAOYSA-N 0.000 claims 1
- TVFJHGFDTWKZLP-UHFFFAOYSA-N 1-(3-ethoxyphenyl)-3-(4-fluorophenyl)urea Chemical compound CCOC1=CC=CC(NC(=O)NC=2C=CC(F)=CC=2)=C1 TVFJHGFDTWKZLP-UHFFFAOYSA-N 0.000 claims 1
- RSXXTDFCOBUTQO-UHFFFAOYSA-N 1-(3-ethylphenyl)-3-(2-thiophen-2-ylethyl)urea Chemical compound CCC1=CC=CC(NC(=O)NCCC=2SC=CC=2)=C1 RSXXTDFCOBUTQO-UHFFFAOYSA-N 0.000 claims 1
- HDSLYONGIAZSGL-UHFFFAOYSA-N 1-(3-fluoro-4-piperidin-1-ylphenyl)-3-(3-methoxyphenyl)urea Chemical compound COC1=CC=CC(NC(=O)NC=2C=C(F)C(N3CCCCC3)=CC=2)=C1 HDSLYONGIAZSGL-UHFFFAOYSA-N 0.000 claims 1
- AQFYAQIEPRFVCM-UHFFFAOYSA-N 1-(3-fluoro-4-piperidin-1-ylphenyl)-3-(3-phenoxyphenyl)urea Chemical compound C=1C=C(N2CCCCC2)C(F)=CC=1NC(=O)NC(C=1)=CC=CC=1OC1=CC=CC=C1 AQFYAQIEPRFVCM-UHFFFAOYSA-N 0.000 claims 1
- ZNOJNJGEHJOGDH-UHFFFAOYSA-N 1-(3-fluoro-4-piperidin-1-ylphenyl)-3-(4-methoxyphenyl)urea Chemical compound C1=CC(OC)=CC=C1NC(=O)NC(C=C1F)=CC=C1N1CCCCC1 ZNOJNJGEHJOGDH-UHFFFAOYSA-N 0.000 claims 1
- LZFITTNRDMKEGK-UHFFFAOYSA-N 1-(3-fluoro-4-piperidin-1-ylphenyl)-3-(4-phenoxyphenyl)urea Chemical compound C=1C=C(N2CCCCC2)C(F)=CC=1NC(=O)NC(C=C1)=CC=C1OC1=CC=CC=C1 LZFITTNRDMKEGK-UHFFFAOYSA-N 0.000 claims 1
- BLNBMTXIHKJKIO-UHFFFAOYSA-N 1-(3-fluoro-4-piperidin-1-ylphenyl)-3-(4-pyrrol-1-ylphenyl)urea Chemical compound C=1C=C(N2CCCCC2)C(F)=CC=1NC(=O)NC(C=C1)=CC=C1N1C=CC=C1 BLNBMTXIHKJKIO-UHFFFAOYSA-N 0.000 claims 1
- FIBCPRWYYQGRJX-UHFFFAOYSA-N 1-(3-fluoro-4-piperidin-1-ylphenyl)-3-[3-(2-methoxyethoxy)phenyl]urea Chemical compound COCCOC1=CC=CC(NC(=O)NC=2C=C(F)C(N3CCCCC3)=CC=2)=C1 FIBCPRWYYQGRJX-UHFFFAOYSA-N 0.000 claims 1
- LEDOGRQUJHSGLQ-UHFFFAOYSA-N 1-(3-fluoro-4-piperidin-1-ylphenyl)-3-[3-(2-methylpyrimidin-4-yl)phenyl]urea Chemical compound CC1=NC=CC(C=2C=C(NC(=O)NC=3C=C(F)C(N4CCCCC4)=CC=3)C=CC=2)=N1 LEDOGRQUJHSGLQ-UHFFFAOYSA-N 0.000 claims 1
- FLTBAILOHFPYHB-UHFFFAOYSA-N 1-(3-fluoro-4-piperidin-1-ylphenyl)-3-[3-(2-morpholin-4-ylethoxy)phenyl]urea Chemical compound C=1C=C(N2CCCCC2)C(F)=CC=1NC(=O)NC(C=1)=CC=CC=1OCCN1CCOCC1 FLTBAILOHFPYHB-UHFFFAOYSA-N 0.000 claims 1
- LMANHEWDGCEAGT-UHFFFAOYSA-N 1-(3-fluoro-4-piperidin-1-ylphenyl)-3-[4-(2-methoxyethoxy)phenyl]urea Chemical compound C1=CC(OCCOC)=CC=C1NC(=O)NC(C=C1F)=CC=C1N1CCCCC1 LMANHEWDGCEAGT-UHFFFAOYSA-N 0.000 claims 1
- YIHYKJQGSMZOTM-UHFFFAOYSA-N 1-(3-fluoro-4-piperidin-1-ylphenyl)-3-[4-(2-morpholin-4-ylethoxy)phenyl]urea Chemical compound C=1C=C(N2CCCCC2)C(F)=CC=1NC(=O)NC(C=C1)=CC=C1OCCN1CCOCC1 YIHYKJQGSMZOTM-UHFFFAOYSA-N 0.000 claims 1
- UGDVFYDFTBOZCP-UHFFFAOYSA-N 1-(3-fluoro-4-piperidin-1-ylphenyl)-3-[4-(2-morpholin-4-ylethyl)phenyl]urea Chemical compound C=1C=C(N2CCCCC2)C(F)=CC=1NC(=O)NC(C=C1)=CC=C1CCN1CCOCC1 UGDVFYDFTBOZCP-UHFFFAOYSA-N 0.000 claims 1
- LXFVOULRFBVUGC-UHFFFAOYSA-N 1-(3-fluoro-4-piperidin-1-ylphenyl)-3-[4-(morpholin-4-ylmethyl)phenyl]urea Chemical compound C=1C=C(N2CCCCC2)C(F)=CC=1NC(=O)NC(C=C1)=CC=C1CN1CCOCC1 LXFVOULRFBVUGC-UHFFFAOYSA-N 0.000 claims 1
- LEVNKKAIINEFLZ-UHFFFAOYSA-N 1-(3-fluoro-4-piperidin-1-ylphenyl)-3-[4-(morpholine-4-carbonyl)phenyl]urea Chemical compound C=1C=C(N2CCCCC2)C(F)=CC=1NC(=O)NC(C=C1)=CC=C1C(=O)N1CCOCC1 LEVNKKAIINEFLZ-UHFFFAOYSA-N 0.000 claims 1
- IDTFCAUUORLWOP-UHFFFAOYSA-N 1-(3-fluoro-4-piperidin-1-ylphenyl)-3-[4-(trifluoromethyl)phenyl]urea Chemical compound C=1C=C(N2CCCCC2)C(F)=CC=1NC(=O)NC1=CC=C(C(F)(F)F)C=C1 IDTFCAUUORLWOP-UHFFFAOYSA-N 0.000 claims 1
- SPRREMVJUIABPB-UHFFFAOYSA-N 1-(4,6-difluoro-1,3-benzothiazol-2-yl)-3-(4-fluorophenyl)urea Chemical compound C1=CC(F)=CC=C1NC(=O)NC1=NC2=C(F)C=C(F)C=C2S1 SPRREMVJUIABPB-UHFFFAOYSA-N 0.000 claims 1
- XVRMXMQXBFZMNK-UHFFFAOYSA-N 1-(4-acetylphenyl)-3-(1-benzothiophen-2-yl)urea Chemical compound C1=CC(C(=O)C)=CC=C1NC(=O)NC1=CC2=CC=CC=C2S1 XVRMXMQXBFZMNK-UHFFFAOYSA-N 0.000 claims 1
- WZWJXMVMKODUKV-UHFFFAOYSA-N 1-(4-acetylphenyl)-3-(2-thiophen-2-ylethyl)urea Chemical compound C1=CC(C(=O)C)=CC=C1NC(=O)NCCC1=CC=CS1 WZWJXMVMKODUKV-UHFFFAOYSA-N 0.000 claims 1
- PWWHZOQXRNMTRH-UHFFFAOYSA-N 1-(4-acetylphenyl)-3-(3-chlorophenyl)urea Chemical compound C1=CC(C(=O)C)=CC=C1NC(=O)NC1=CC=CC(Cl)=C1 PWWHZOQXRNMTRH-UHFFFAOYSA-N 0.000 claims 1
- GCFNQQSTIWCXQI-UHFFFAOYSA-N 1-(4-acetylphenyl)-3-(4-bromophenyl)urea Chemical compound C1=CC(C(=O)C)=CC=C1NC(=O)NC1=CC=C(Br)C=C1 GCFNQQSTIWCXQI-UHFFFAOYSA-N 0.000 claims 1
- UAUZMDODFFNVLK-UHFFFAOYSA-N 1-(4-acetylphenyl)-3-(4-chlorophenyl)urea Chemical compound C1=CC(C(=O)C)=CC=C1NC(=O)NC1=CC=C(Cl)C=C1 UAUZMDODFFNVLK-UHFFFAOYSA-N 0.000 claims 1
- LPHLTXDENVFIFV-UHFFFAOYSA-N 1-(4-acetylphenyl)-3-(4-fluorophenyl)urea Chemical compound C1=CC(C(=O)C)=CC=C1NC(=O)NC1=CC=C(F)C=C1 LPHLTXDENVFIFV-UHFFFAOYSA-N 0.000 claims 1
- XKWCNKLCTJNILQ-UHFFFAOYSA-N 1-(4-acetylphenyl)-3-[3-(6-methoxypyridin-2-yl)phenyl]urea Chemical compound COC1=CC=CC(C=2C=C(NC(=O)NC=3C=CC(=CC=3)C(C)=O)C=CC=2)=N1 XKWCNKLCTJNILQ-UHFFFAOYSA-N 0.000 claims 1
- HZAUXMLGDZGWSL-UHFFFAOYSA-N 1-(4-acetylphenyl)-3-[4-(morpholin-4-ylmethyl)phenyl]urea Chemical compound C1=CC(C(=O)C)=CC=C1NC(=O)NC(C=C1)=CC=C1CN1CCOCC1 HZAUXMLGDZGWSL-UHFFFAOYSA-N 0.000 claims 1
- MGLCGFOXGUKYEK-UHFFFAOYSA-N 1-(4-acetylphenyl)-3-[4-(morpholine-4-carbonyl)phenyl]urea Chemical compound C1=CC(C(=O)C)=CC=C1NC(=O)NC1=CC=C(C(=O)N2CCOCC2)C=C1 MGLCGFOXGUKYEK-UHFFFAOYSA-N 0.000 claims 1
- ZVFDWRDGTDFQDX-UHFFFAOYSA-N 1-(4-benzoylphenyl)-3-(4-fluorophenyl)urea Chemical compound C1=CC(F)=CC=C1NC(=O)NC1=CC=C(C(=O)C=2C=CC=CC=2)C=C1 ZVFDWRDGTDFQDX-UHFFFAOYSA-N 0.000 claims 1
- AFAJUVLPTHBGBV-UHFFFAOYSA-N 1-(4-butanoylphenyl)-3-(4-fluorophenyl)urea Chemical compound C1=CC(C(=O)CCC)=CC=C1NC(=O)NC1=CC=C(F)C=C1 AFAJUVLPTHBGBV-UHFFFAOYSA-N 0.000 claims 1
- CSNXMKVKRTZYNY-UHFFFAOYSA-N 1-(4-butanoylphenyl)-3-(4-piperidin-1-ylphenyl)urea Chemical compound C1=CC(C(=O)CCC)=CC=C1NC(=O)NC1=CC=C(N2CCCCC2)C=C1 CSNXMKVKRTZYNY-UHFFFAOYSA-N 0.000 claims 1
- RDKSSLNOBXGBKC-UHFFFAOYSA-N 1-(4-butanoylphenyl)-3-[4-(morpholine-4-carbonyl)phenyl]urea Chemical compound C1=CC(C(=O)CCC)=CC=C1NC(=O)NC1=CC=C(C(=O)N2CCOCC2)C=C1 RDKSSLNOBXGBKC-UHFFFAOYSA-N 0.000 claims 1
- IZHKUKPBDUZXPQ-UHFFFAOYSA-N 1-(4-butylphenyl)-3-(2-thiophen-2-ylethyl)urea Chemical compound C1=CC(CCCC)=CC=C1NC(=O)NCCC1=CC=CS1 IZHKUKPBDUZXPQ-UHFFFAOYSA-N 0.000 claims 1
- KXFJKWDLKTUVAT-UHFFFAOYSA-N 1-(4-chloro-2-hydroxyphenyl)-3-(3-fluoro-4-piperidin-1-ylphenyl)urea Chemical compound OC1=CC(Cl)=CC=C1NC(=O)NC(C=C1F)=CC=C1N1CCCCC1 KXFJKWDLKTUVAT-UHFFFAOYSA-N 0.000 claims 1
- TXUXJSJVLGJQBP-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-(1-methylindazol-5-yl)urea Chemical compound C=1C=C2N(C)N=CC2=CC=1NC(=O)NC1=CC=C(Cl)C=C1 TXUXJSJVLGJQBP-UHFFFAOYSA-N 0.000 claims 1
- GOTKACBYTSNYTK-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-(2-thiophen-2-ylethyl)urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NCCC1=CC=CS1 GOTKACBYTSNYTK-UHFFFAOYSA-N 0.000 claims 1
- KACJXLXAPNNLPU-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-(3-fluoro-4-morpholin-4-ylphenyl)urea Chemical compound C=1C=C(N2CCOCC2)C(F)=CC=1NC(=O)NC1=CC=C(Cl)C=C1 KACJXLXAPNNLPU-UHFFFAOYSA-N 0.000 claims 1
- CZMDEJFFFFUWNT-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-(3-fluoro-4-piperidin-1-ylphenyl)urea Chemical compound C=1C=C(N2CCCCC2)C(F)=CC=1NC(=O)NC1=CC=C(Cl)C=C1 CZMDEJFFFFUWNT-UHFFFAOYSA-N 0.000 claims 1
- AFESQBQGMRQPJV-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-(3-fluoro-4-pyrrolidin-1-ylphenyl)urea Chemical compound C=1C=C(N2CCCC2)C(F)=CC=1NC(=O)NC1=CC=C(Cl)C=C1 AFESQBQGMRQPJV-UHFFFAOYSA-N 0.000 claims 1
- CEQBJLQGCDDUCY-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-(3-pyrazol-1-ylphenyl)urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=CC(N2N=CC=C2)=C1 CEQBJLQGCDDUCY-UHFFFAOYSA-N 0.000 claims 1
- LDENYLOBHSGDFQ-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-(4-ethoxyphenyl)urea Chemical compound C1=CC(OCC)=CC=C1NC(=O)NC1=CC=C(Cl)C=C1 LDENYLOBHSGDFQ-UHFFFAOYSA-N 0.000 claims 1
- QRARSYHMOSMDLP-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-(4-piperidin-1-ylphenyl)urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(N2CCCCC2)C=C1 QRARSYHMOSMDLP-UHFFFAOYSA-N 0.000 claims 1
- GPELLUQEAIOOFT-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-(4-pyrazol-1-ylphenyl)urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(N2N=CC=C2)C=C1 GPELLUQEAIOOFT-UHFFFAOYSA-N 0.000 claims 1
- YVARUFYOIMDIHP-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-(4-pyridin-2-ylphenyl)urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(C=2N=CC=CC=2)C=C1 YVARUFYOIMDIHP-UHFFFAOYSA-N 0.000 claims 1
- XJIGCFRVXGTBGY-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-(4-pyridin-3-ylphenyl)urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(C=2C=NC=CC=2)C=C1 XJIGCFRVXGTBGY-UHFFFAOYSA-N 0.000 claims 1
- OTWXSQUYQCLHAE-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-(4-pyridin-4-ylphenyl)urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(C=2C=CN=CC=2)C=C1 OTWXSQUYQCLHAE-UHFFFAOYSA-N 0.000 claims 1
- WPNVUCMDRCDDOE-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-(4-pyrrol-1-ylphenyl)urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(N2C=CC=C2)C=C1 WPNVUCMDRCDDOE-UHFFFAOYSA-N 0.000 claims 1
- MHGKQRJCERMRFU-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[3-(2-methylpyrimidin-4-yl)phenyl]urea Chemical compound CC1=NC=CC(C=2C=C(NC(=O)NC=3C=CC(Cl)=CC=3)C=CC=2)=N1 MHGKQRJCERMRFU-UHFFFAOYSA-N 0.000 claims 1
- DTXBYPGBGCGVRO-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[3-(2-piperidin-1-ylpyrimidin-4-yl)phenyl]urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=CC(C=2N=C(N=CC=2)N2CCCCC2)=C1 DTXBYPGBGCGVRO-UHFFFAOYSA-N 0.000 claims 1
- AVAKEEARPNMNRJ-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[3-(2-propan-2-ylpyrimidin-4-yl)phenyl]urea Chemical compound CC(C)C1=NC=CC(C=2C=C(NC(=O)NC=3C=CC(Cl)=CC=3)C=CC=2)=N1 AVAKEEARPNMNRJ-UHFFFAOYSA-N 0.000 claims 1
- NKGIFOQCBMXHAI-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[3-(2-pyrrolidin-1-ylpyrimidin-4-yl)phenyl]urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=CC(C=2N=C(N=CC=2)N2CCCC2)=C1 NKGIFOQCBMXHAI-UHFFFAOYSA-N 0.000 claims 1
- UUFRJYJLCSHCIU-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[3-(6-methylpyrimidin-4-yl)phenyl]urea Chemical compound C1=NC(C)=CC(C=2C=C(NC(=O)NC=3C=CC(Cl)=CC=3)C=CC=2)=N1 UUFRJYJLCSHCIU-UHFFFAOYSA-N 0.000 claims 1
- WTZBQRKRMSBFEP-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[3-(6-piperidin-1-ylpyridin-2-yl)phenyl]urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=CC(C=2N=C(C=CC=2)N2CCCCC2)=C1 WTZBQRKRMSBFEP-UHFFFAOYSA-N 0.000 claims 1
- HDAYFSFWIPRJSO-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[3-(6-pyrrolidin-1-ylpyridin-2-yl)phenyl]urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=CC(C=2N=C(C=CC=2)N2CCCC2)=C1 HDAYFSFWIPRJSO-UHFFFAOYSA-N 0.000 claims 1
- CVBNKZWOKXHXIY-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[3-(dimethylamino)phenyl]urea Chemical compound CN(C)C1=CC=CC(NC(=O)NC=2C=CC(Cl)=CC=2)=C1 CVBNKZWOKXHXIY-UHFFFAOYSA-N 0.000 claims 1
- ZLPCRPPAHQITJH-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[3-fluoro-4-(2-methylpiperidin-1-yl)phenyl]urea Chemical compound CC1CCCCN1C(C(=C1)F)=CC=C1NC(=O)NC1=CC=C(Cl)C=C1 ZLPCRPPAHQITJH-UHFFFAOYSA-N 0.000 claims 1
- GCCQCUNRCCRTHI-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[3-fluoro-4-(3-hydroxypiperidin-1-yl)phenyl]urea Chemical compound C1C(O)CCCN1C(C(=C1)F)=CC=C1NC(=O)NC1=CC=C(Cl)C=C1 GCCQCUNRCCRTHI-UHFFFAOYSA-N 0.000 claims 1
- RFZCWMVZZYXFCV-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[3-fluoro-4-(3-methylpiperidin-1-yl)phenyl]urea Chemical compound C1C(C)CCCN1C(C(=C1)F)=CC=C1NC(=O)NC1=CC=C(Cl)C=C1 RFZCWMVZZYXFCV-UHFFFAOYSA-N 0.000 claims 1
- OWFZUBZPOVCNKB-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[3-fluoro-4-(4-hydroxypiperidin-1-yl)phenyl]urea Chemical compound C1CC(O)CCN1C(C(=C1)F)=CC=C1NC(=O)NC1=CC=C(Cl)C=C1 OWFZUBZPOVCNKB-UHFFFAOYSA-N 0.000 claims 1
- JJUWXUOUSINEQN-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[3-fluoro-4-(4-methylpiperidin-1-yl)phenyl]urea Chemical compound C1CC(C)CCN1C(C(=C1)F)=CC=C1NC(=O)NC1=CC=C(Cl)C=C1 JJUWXUOUSINEQN-UHFFFAOYSA-N 0.000 claims 1
- LXCGZBBJUQPQON-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[4-(3,4-dihydro-1h-isoquinolin-2-yl)-3-fluorophenyl]urea Chemical compound C=1C=C(N2CC3=CC=CC=C3CC2)C(F)=CC=1NC(=O)NC1=CC=C(Cl)C=C1 LXCGZBBJUQPQON-UHFFFAOYSA-N 0.000 claims 1
- ZEUZRMBHGWYSIZ-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[4-(4,4-difluoropiperidin-1-yl)-3-fluorophenyl]urea Chemical compound C=1C=C(N2CCC(F)(F)CC2)C(F)=CC=1NC(=O)NC1=CC=C(Cl)C=C1 ZEUZRMBHGWYSIZ-UHFFFAOYSA-N 0.000 claims 1
- RVNGRLFWDMOUIJ-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[4-(morpholin-4-ylmethyl)phenyl]urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC(C=C1)=CC=C1CN1CCOCC1 RVNGRLFWDMOUIJ-UHFFFAOYSA-N 0.000 claims 1
- CLYRAZNPXRXMEQ-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[4-(morpholine-4-carbonyl)phenyl]urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(C(=O)N2CCOCC2)C=C1 CLYRAZNPXRXMEQ-UHFFFAOYSA-N 0.000 claims 1
- ABBLDJYIOUVXKT-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-[4-(trifluoromethoxy)phenyl]urea Chemical compound C1=CC(OC(F)(F)F)=CC=C1NC(=O)NC1=CC=C(Cl)C=C1 ABBLDJYIOUVXKT-UHFFFAOYSA-N 0.000 claims 1
- ULOZPLLSFCZXDI-UHFFFAOYSA-N 1-(4-cyanophenyl)-3-(3-fluoro-4-piperidin-1-ylphenyl)urea Chemical compound C=1C=C(N2CCCCC2)C(F)=CC=1NC(=O)NC1=CC=C(C#N)C=C1 ULOZPLLSFCZXDI-UHFFFAOYSA-N 0.000 claims 1
- GGFGTTCVGNTUSN-UHFFFAOYSA-N 1-(4-ethoxyphenyl)-3-(4-fluorophenyl)urea Chemical compound C1=CC(OCC)=CC=C1NC(=O)NC1=CC=C(F)C=C1 GGFGTTCVGNTUSN-UHFFFAOYSA-N 0.000 claims 1
- RXTQMJCZELFWJD-UHFFFAOYSA-N 1-(4-ethylphenyl)-3-(2-thiophen-2-ylethyl)urea Chemical compound C1=CC(CC)=CC=C1NC(=O)NCCC1=CC=CS1 RXTQMJCZELFWJD-UHFFFAOYSA-N 0.000 claims 1
- SIOGSYUBTIPNNZ-UHFFFAOYSA-N 1-(4-ethylphenyl)-3-(3-fluoro-4-piperidin-1-ylphenyl)urea Chemical compound C1=CC(CC)=CC=C1NC(=O)NC(C=C1F)=CC=C1N1CCCCC1 SIOGSYUBTIPNNZ-UHFFFAOYSA-N 0.000 claims 1
- CHWXAWOJTKMBEB-UHFFFAOYSA-N 1-(4-fluoro-3-methylphenyl)-3-(4-fluorophenyl)urea Chemical compound C1=C(F)C(C)=CC(NC(=O)NC=2C=CC(F)=CC=2)=C1 CHWXAWOJTKMBEB-UHFFFAOYSA-N 0.000 claims 1
- VZBDFNOZZHSPJN-UHFFFAOYSA-N 1-(4-fluorophenyl)-3-(2-methyl-1,3-benzothiazol-5-yl)urea Chemical compound C=1C=C2SC(C)=NC2=CC=1NC(=O)NC1=CC=C(F)C=C1 VZBDFNOZZHSPJN-UHFFFAOYSA-N 0.000 claims 1
- NPCMYFOQLHUOEE-UHFFFAOYSA-N 1-(4-fluorophenyl)-3-(2-thiophen-2-ylethyl)urea Chemical compound C1=CC(F)=CC=C1NC(=O)NCCC1=CC=CS1 NPCMYFOQLHUOEE-UHFFFAOYSA-N 0.000 claims 1
- WSWWPBBUFFQNHR-UHFFFAOYSA-N 1-(4-fluorophenyl)-3-(3-fluoro-4-piperidin-1-ylphenyl)urea Chemical compound C1=CC(F)=CC=C1NC(=O)NC(C=C1F)=CC=C1N1CCCCC1 WSWWPBBUFFQNHR-UHFFFAOYSA-N 0.000 claims 1
- UAUKRBCEKBVTHE-UHFFFAOYSA-N 1-(4-fluorophenyl)-3-(4-imidazol-1-ylphenyl)urea Chemical compound C1=CC(F)=CC=C1NC(=O)NC1=CC=C(N2C=NC=C2)C=C1 UAUKRBCEKBVTHE-UHFFFAOYSA-N 0.000 claims 1
- TYFLHNPOKOIZSJ-UHFFFAOYSA-N 1-(4-fluorophenyl)-3-(4-methoxyphenyl)urea Chemical compound C1=CC(OC)=CC=C1NC(=O)NC1=CC=C(F)C=C1 TYFLHNPOKOIZSJ-UHFFFAOYSA-N 0.000 claims 1
- SHTOGKSTTKTWSU-UHFFFAOYSA-N 1-(4-fluorophenyl)-3-(4-morpholin-4-ylphenyl)urea Chemical compound C1=CC(F)=CC=C1NC(=O)NC1=CC=C(N2CCOCC2)C=C1 SHTOGKSTTKTWSU-UHFFFAOYSA-N 0.000 claims 1
- IVXCZNOTNADILF-UHFFFAOYSA-N 1-(4-fluorophenyl)-3-(4-propanoylphenyl)urea Chemical compound C1=CC(C(=O)CC)=CC=C1NC(=O)NC1=CC=C(F)C=C1 IVXCZNOTNADILF-UHFFFAOYSA-N 0.000 claims 1
- OUUVTPBRUNHLOY-UHFFFAOYSA-N 1-(4-fluorophenyl)-3-(4-pyrrol-1-ylphenyl)urea Chemical compound C1=CC(F)=CC=C1NC(=O)NC1=CC=C(N2C=CC=C2)C=C1 OUUVTPBRUNHLOY-UHFFFAOYSA-N 0.000 claims 1
- XLDXXNFUGHTPOL-UHFFFAOYSA-N 1-(4-fluorophenyl)-3-(6-methoxy-1,3-benzothiazol-2-yl)urea Chemical compound S1C2=CC(OC)=CC=C2N=C1NC(=O)NC1=CC=C(F)C=C1 XLDXXNFUGHTPOL-UHFFFAOYSA-N 0.000 claims 1
- ZVKBKYHKEYIQNE-UHFFFAOYSA-N 1-(4-fluorophenyl)-3-[3-(1,3-oxazol-5-yl)phenyl]urea Chemical compound C1=CC(F)=CC=C1NC(=O)NC1=CC=CC(C=2OC=NC=2)=C1 ZVKBKYHKEYIQNE-UHFFFAOYSA-N 0.000 claims 1
- LARKFLKWTSNPQX-UHFFFAOYSA-N 1-(4-fluorophenyl)-3-[3-(2-methylpyrimidin-4-yl)phenyl]urea Chemical compound CC1=NC=CC(C=2C=C(NC(=O)NC=3C=CC(F)=CC=3)C=CC=2)=N1 LARKFLKWTSNPQX-UHFFFAOYSA-N 0.000 claims 1
- AQBKFXAFGSDPCT-UHFFFAOYSA-N 1-(4-fluorophenyl)-3-[4-(2-methylpyrimidin-4-yl)phenyl]urea Chemical compound CC1=NC=CC(C=2C=CC(NC(=O)NC=3C=CC(F)=CC=3)=CC=2)=N1 AQBKFXAFGSDPCT-UHFFFAOYSA-N 0.000 claims 1
- RNAUXLSHGTWVNV-UHFFFAOYSA-N 1-(4-methoxyphenyl)-3-(2-thiophen-2-ylethyl)urea Chemical compound C1=CC(OC)=CC=C1NC(=O)NCCC1=CC=CS1 RNAUXLSHGTWVNV-UHFFFAOYSA-N 0.000 claims 1
- MZEQAXFSSLFSEQ-UHFFFAOYSA-N 1-(4-methylphenyl)-3-(2-thiophen-2-ylethyl)urea Chemical compound C1=CC(C)=CC=C1NC(=O)NCCC1=CC=CS1 MZEQAXFSSLFSEQ-UHFFFAOYSA-N 0.000 claims 1
- KGLCDMHPQPTUTD-UHFFFAOYSA-N 1-(4-methylsulfanylphenyl)-3-(2-thiophen-2-ylethyl)urea Chemical compound C1=CC(SC)=CC=C1NC(=O)NCCC1=CC=CS1 KGLCDMHPQPTUTD-UHFFFAOYSA-N 0.000 claims 1
- FHIWZSBQVLFVQY-UHFFFAOYSA-N 1-(4-propan-2-ylphenyl)-3-(1,3-thiazol-2-yl)urea Chemical compound C1=CC(C(C)C)=CC=C1NC(=O)NC1=NC=CS1 FHIWZSBQVLFVQY-UHFFFAOYSA-N 0.000 claims 1
- GQBHOOKASKSSDK-UHFFFAOYSA-N 1-(4-propan-2-ylphenyl)-3-(2-thiophen-2-ylethyl)urea Chemical compound C1=CC(C(C)C)=CC=C1NC(=O)NCCC1=CC=CS1 GQBHOOKASKSSDK-UHFFFAOYSA-N 0.000 claims 1
- CXPJNCCNKYBAOQ-UHFFFAOYSA-N 1-(6-chloro-1,3-benzothiazol-2-yl)-3-(4-fluorophenyl)urea Chemical compound C1=CC(F)=CC=C1NC(=O)NC1=NC2=CC=C(Cl)C=C2S1 CXPJNCCNKYBAOQ-UHFFFAOYSA-N 0.000 claims 1
- ISGYVSPOSLFEDG-UHFFFAOYSA-N 1-(6-fluoro-1,3-benzothiazol-2-yl)-3-(4-fluorophenyl)urea Chemical compound C1=CC(F)=CC=C1NC(=O)NC1=NC2=CC=C(F)C=C2S1 ISGYVSPOSLFEDG-UHFFFAOYSA-N 0.000 claims 1
- TWROWRBGMVREFW-UHFFFAOYSA-N 1-[2-(2-fluorophenyl)ethyl]-3-(4-propan-2-ylphenyl)urea Chemical compound C1=CC(C(C)C)=CC=C1NC(=O)NCCC1=CC=CC=C1F TWROWRBGMVREFW-UHFFFAOYSA-N 0.000 claims 1
- KVJHOQZXBVVVRU-UHFFFAOYSA-N 1-[2-(3-fluorophenyl)ethyl]-3-(4-propan-2-ylphenyl)urea Chemical compound C1=CC(C(C)C)=CC=C1NC(=O)NCCC1=CC=CC(F)=C1 KVJHOQZXBVVVRU-UHFFFAOYSA-N 0.000 claims 1
- AVOXMLCOFXYKNI-UHFFFAOYSA-N 1-[2-(3-fluorophenyl)ethyl]-3-[4-(trifluoromethyl)phenyl]urea Chemical compound FC1=CC=CC(CCNC(=O)NC=2C=CC(=CC=2)C(F)(F)F)=C1 AVOXMLCOFXYKNI-UHFFFAOYSA-N 0.000 claims 1
- LYBWJLTXCIFNOD-UHFFFAOYSA-N 1-[2-(4-chlorophenyl)ethyl]-3-(3-pyrrol-1-ylphenyl)urea Chemical compound C1=CC(Cl)=CC=C1CCNC(=O)NC1=CC=CC(N2C=CC=C2)=C1 LYBWJLTXCIFNOD-UHFFFAOYSA-N 0.000 claims 1
- UBLVUDLTTYSKJH-UHFFFAOYSA-N 1-[2-(4-chlorophenyl)ethyl]-3-[3-(2-methylpyrazol-3-yl)phenyl]urea Chemical compound CN1N=CC=C1C1=CC=CC(NC(=O)NCCC=2C=CC(Cl)=CC=2)=C1 UBLVUDLTTYSKJH-UHFFFAOYSA-N 0.000 claims 1
- PSPMNALXLAXKRV-UHFFFAOYSA-N 1-[2-(4-chlorophenyl)ethyl]-3-[3-(2-methylpyrimidin-4-yl)phenyl]urea Chemical compound CC1=NC=CC(C=2C=C(NC(=O)NCCC=3C=CC(Cl)=CC=3)C=CC=2)=N1 PSPMNALXLAXKRV-UHFFFAOYSA-N 0.000 claims 1
- SYUXQHQHYJRXHY-UHFFFAOYSA-N 1-[2-(4-chlorophenyl)ethyl]-3-[4-(morpholin-4-ylmethyl)phenyl]urea Chemical compound C1=CC(Cl)=CC=C1CCNC(=O)NC(C=C1)=CC=C1CN1CCOCC1 SYUXQHQHYJRXHY-UHFFFAOYSA-N 0.000 claims 1
- XFLDXXIOBPPJGB-UHFFFAOYSA-N 1-[2-(4-chlorophenyl)ethyl]-3-[4-(morpholine-4-carbonyl)phenyl]urea Chemical compound C1=CC(Cl)=CC=C1CCNC(=O)NC1=CC=C(C(=O)N2CCOCC2)C=C1 XFLDXXIOBPPJGB-UHFFFAOYSA-N 0.000 claims 1
- NDFPXJXBKCHPET-UHFFFAOYSA-N 1-[4-(azepan-1-yl)-3-fluorophenyl]-3-(4-chlorophenyl)urea Chemical compound C=1C=C(N2CCCCCC2)C(F)=CC=1NC(=O)NC1=CC=C(Cl)C=C1 NDFPXJXBKCHPET-UHFFFAOYSA-N 0.000 claims 1
- NCYUZEUZAVSISY-UHFFFAOYSA-N 1-[4-(difluoromethoxy)phenyl]-3-(2-thiophen-2-ylethyl)urea Chemical compound C1=CC(OC(F)F)=CC=C1NC(=O)NCCC1=CC=CS1 NCYUZEUZAVSISY-UHFFFAOYSA-N 0.000 claims 1
- FHWPUKBCEZAXOD-UHFFFAOYSA-N 1-[4-(morpholin-4-ylmethyl)phenyl]-3-(3-pyrrol-1-ylphenyl)urea Chemical compound C=1C=CC(N2C=CC=C2)=CC=1NC(=O)NC(C=C1)=CC=C1CN1CCOCC1 FHWPUKBCEZAXOD-UHFFFAOYSA-N 0.000 claims 1
- XJFWBDLBDABUJH-UHFFFAOYSA-N 1-[4-(morpholin-4-ylmethyl)phenyl]-3-(4-pyrazol-1-ylphenyl)urea Chemical compound C=1C=C(N2N=CC=C2)C=CC=1NC(=O)NC(C=C1)=CC=C1CN1CCOCC1 XJFWBDLBDABUJH-UHFFFAOYSA-N 0.000 claims 1
- ZOBSPYRFLHSDBP-UHFFFAOYSA-N 1-[4-(morpholin-4-ylmethyl)phenyl]-3-(4-pyrrol-1-ylphenyl)urea Chemical compound C=1C=C(N2C=CC=C2)C=CC=1NC(=O)NC(C=C1)=CC=C1CN1CCOCC1 ZOBSPYRFLHSDBP-UHFFFAOYSA-N 0.000 claims 1
- ZMJGJTJUDJFGGZ-UHFFFAOYSA-N 1-[4-chloro-3-(trifluoromethyl)phenyl]-3-(3-fluoro-4-piperidin-1-ylphenyl)urea Chemical compound C=1C=C(N2CCCCC2)C(F)=CC=1NC(=O)NC1=CC=C(Cl)C(C(F)(F)F)=C1 ZMJGJTJUDJFGGZ-UHFFFAOYSA-N 0.000 claims 1
- VRCLDQPZBUPNBI-UHFFFAOYSA-N 2-[4-[(4-ethoxycarbonylphenyl)carbamoylamino]phenyl]acetic acid Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(CC(O)=O)C=C1 VRCLDQPZBUPNBI-UHFFFAOYSA-N 0.000 claims 1
- MTZMRKVRYDMVJN-UHFFFAOYSA-N 2-methylpropyl 4-[(4-fluorophenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC(C)C)=CC=C1NC(=O)NC1=CC=C(F)C=C1 MTZMRKVRYDMVJN-UHFFFAOYSA-N 0.000 claims 1
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 1
- 125000003341 7 membered heterocyclic group Chemical group 0.000 claims 1
- 208000007848 Alcoholism Diseases 0.000 claims 1
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 208000020925 Bipolar disease Diseases 0.000 claims 1
- 208000032841 Bulimia Diseases 0.000 claims 1
- 206010006550 Bulimia nervosa Diseases 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- 208000028698 Cognitive impairment Diseases 0.000 claims 1
- 206010012335 Dependence Diseases 0.000 claims 1
- 208000027534 Emotional disease Diseases 0.000 claims 1
- 208000003698 Heroin Dependence Diseases 0.000 claims 1
- 208000023105 Huntington disease Diseases 0.000 claims 1
- 208000001953 Hypotension Diseases 0.000 claims 1
- 206010021333 Ileus paralytic Diseases 0.000 claims 1
- 201000005081 Intestinal Pseudo-Obstruction Diseases 0.000 claims 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 claims 1
- 208000019430 Motor disease Diseases 0.000 claims 1
- 208000012902 Nervous system disease Diseases 0.000 claims 1
- 208000025966 Neurological disease Diseases 0.000 claims 1
- 241000208125 Nicotiana Species 0.000 claims 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims 1
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 208000028017 Psychotic disease Diseases 0.000 claims 1
- 208000003782 Raynaud disease Diseases 0.000 claims 1
- 208000012322 Raynaud phenomenon Diseases 0.000 claims 1
- 206010040070 Septic Shock Diseases 0.000 claims 1
- 125000004414 alkyl thio group Chemical group 0.000 claims 1
- 208000022531 anorexia Diseases 0.000 claims 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims 1
- RQWWFAOIIYPQOC-UHFFFAOYSA-N butyl 4-[(4-fluorophenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCCCC)=CC=C1NC(=O)NC1=CC=C(F)C=C1 RQWWFAOIIYPQOC-UHFFFAOYSA-N 0.000 claims 1
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 claims 1
- 229960003920 cocaine Drugs 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 206010061428 decreased appetite Diseases 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 206010013663 drug dependence Diseases 0.000 claims 1
- 230000002526 effect on cardiovascular system Effects 0.000 claims 1
- 230000002996 emotional effect Effects 0.000 claims 1
- 208000030172 endocrine system disease Diseases 0.000 claims 1
- 239000002158 endotoxin Substances 0.000 claims 1
- 206010015037 epilepsy Diseases 0.000 claims 1
- BPZQYRKBIDVMEA-UHFFFAOYSA-N ethyl 2-[(3-fluorophenyl)carbamoylamino]-4-methyl-1,3-thiazole-5-carboxylate Chemical compound CC1=C(C(=O)OCC)SC(NC(=O)NC=2C=C(F)C=CC=2)=N1 BPZQYRKBIDVMEA-UHFFFAOYSA-N 0.000 claims 1
- WUPMYPGMUZKRCG-UHFFFAOYSA-N ethyl 2-[(4-ethoxycarbonylphenyl)carbamoylamino]-4-methyl-1,3-thiazole-5-carboxylate Chemical compound CC1=C(C(=O)OCC)SC(NC(=O)NC=2C=CC(=CC=2)C(=O)OCC)=N1 WUPMYPGMUZKRCG-UHFFFAOYSA-N 0.000 claims 1
- MNNRVKHHNVWGMB-UHFFFAOYSA-N ethyl 2-[(4-ethoxycarbonylphenyl)carbamoylamino]-4-methylpyrimidine-5-carboxylate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=NC=C(C(=O)OCC)C(C)=N1 MNNRVKHHNVWGMB-UHFFFAOYSA-N 0.000 claims 1
- VQFQYNMOQQRZTP-UHFFFAOYSA-N ethyl 2-[(4-fluorophenyl)carbamoylamino]-4-methyl-1,3-thiazole-5-carboxylate Chemical compound CC1=C(C(=O)OCC)SC(NC(=O)NC=2C=CC(F)=CC=2)=N1 VQFQYNMOQQRZTP-UHFFFAOYSA-N 0.000 claims 1
- FEOCWWBYAPFFOF-UHFFFAOYSA-N ethyl 2-[4-[(4-fluorophenyl)carbamoylamino]phenyl]acetate Chemical compound C1=CC(CC(=O)OCC)=CC=C1NC(=O)NC1=CC=C(F)C=C1 FEOCWWBYAPFFOF-UHFFFAOYSA-N 0.000 claims 1
- LQIGNEFYRGFEDC-UHFFFAOYSA-N ethyl 2-chloro-4-[(4-ethoxycarbonylphenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(C(=O)OCC)C(Cl)=C1 LQIGNEFYRGFEDC-UHFFFAOYSA-N 0.000 claims 1
- SKEVEEGSJFZINO-UHFFFAOYSA-N ethyl 2-chloro-4-[(4-fluorophenyl)carbamoylamino]benzoate Chemical compound C1=C(Cl)C(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(F)C=C1 SKEVEEGSJFZINO-UHFFFAOYSA-N 0.000 claims 1
- NZCPJZPQSHPVJP-UHFFFAOYSA-N ethyl 3-[(4-ethoxycarbonylphenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=CC(C(=O)OCC)=C1 NZCPJZPQSHPVJP-UHFFFAOYSA-N 0.000 claims 1
- ARNPJTWYVZQXNP-UHFFFAOYSA-N ethyl 3-[(4-fluorophenyl)carbamoylamino]benzoate Chemical compound CCOC(=O)C1=CC=CC(NC(=O)NC=2C=CC(F)=CC=2)=C1 ARNPJTWYVZQXNP-UHFFFAOYSA-N 0.000 claims 1
- WBPAFUYWRGKQSG-UHFFFAOYSA-N ethyl 4-(1,3-benzothiazol-6-ylcarbamoylamino)benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(N=CS2)C2=C1 WBPAFUYWRGKQSG-UHFFFAOYSA-N 0.000 claims 1
- APQFMDQPXNKLIK-UHFFFAOYSA-N ethyl 4-(1h-indol-5-ylcarbamoylamino)benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(NC=C2)C2=C1 APQFMDQPXNKLIK-UHFFFAOYSA-N 0.000 claims 1
- SLPNRBSFKWMCLO-UHFFFAOYSA-N ethyl 4-(1h-indol-6-ylcarbamoylamino)benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(C=CN2)C2=C1 SLPNRBSFKWMCLO-UHFFFAOYSA-N 0.000 claims 1
- MWOQTMMZHFJCJJ-UHFFFAOYSA-N ethyl 4-[(1-oxo-2,3-dihydroinden-5-yl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(C(=O)CC2)C2=C1 MWOQTMMZHFJCJJ-UHFFFAOYSA-N 0.000 claims 1
- PAKLYGYPZZDNHP-UHFFFAOYSA-N ethyl 4-[(2,4,6-trifluorophenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=C(F)C=C(F)C=C1F PAKLYGYPZZDNHP-UHFFFAOYSA-N 0.000 claims 1
- LDWCZSHKVJNSDS-UHFFFAOYSA-N ethyl 4-[(2,4-difluorophenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(F)C=C1F LDWCZSHKVJNSDS-UHFFFAOYSA-N 0.000 claims 1
- YRGLBYFSDMQLGB-UHFFFAOYSA-N ethyl 4-[(2-chloro-4-fluorophenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(F)C=C1Cl YRGLBYFSDMQLGB-UHFFFAOYSA-N 0.000 claims 1
- SIDAXTZGQQRWLY-UHFFFAOYSA-N ethyl 4-[(2-chlorophenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=CC=C1Cl SIDAXTZGQQRWLY-UHFFFAOYSA-N 0.000 claims 1
- VBTZVXMYIIFSRH-UHFFFAOYSA-N ethyl 4-[(2-fluorophenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=CC=C1F VBTZVXMYIIFSRH-UHFFFAOYSA-N 0.000 claims 1
- UCURJVGAHFXOGM-UHFFFAOYSA-N ethyl 4-[(3,4-difluorophenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(F)C(F)=C1 UCURJVGAHFXOGM-UHFFFAOYSA-N 0.000 claims 1
- HEBDWBCMYBFGHJ-UHFFFAOYSA-N ethyl 4-[(3-acetylphenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=CC(C(C)=O)=C1 HEBDWBCMYBFGHJ-UHFFFAOYSA-N 0.000 claims 1
- LGWMNYOKMADBBG-UHFFFAOYSA-N ethyl 4-[(3-chloro-4-fluorophenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(F)C(Cl)=C1 LGWMNYOKMADBBG-UHFFFAOYSA-N 0.000 claims 1
- CYVYCDVRLVZJEI-UHFFFAOYSA-N ethyl 4-[(3-chlorophenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=CC(Cl)=C1 CYVYCDVRLVZJEI-UHFFFAOYSA-N 0.000 claims 1
- BWJMOOIEZAIDQB-UHFFFAOYSA-N ethyl 4-[(3-fluoro-4-piperidin-1-ylphenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC(C=C1F)=CC=C1N1CCCCC1 BWJMOOIEZAIDQB-UHFFFAOYSA-N 0.000 claims 1
- KVXMNXYDSOBVIQ-UHFFFAOYSA-N ethyl 4-[(3-fluorophenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=CC(F)=C1 KVXMNXYDSOBVIQ-UHFFFAOYSA-N 0.000 claims 1
- GTEYFMXYOAMRLE-UHFFFAOYSA-N ethyl 4-[(4-acetylphenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(C(C)=O)C=C1 GTEYFMXYOAMRLE-UHFFFAOYSA-N 0.000 claims 1
- BDKSFIXEFIZUBX-UHFFFAOYSA-N ethyl 4-[(4-benzoylphenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(C(=O)C=2C=CC=CC=2)C=C1 BDKSFIXEFIZUBX-UHFFFAOYSA-N 0.000 claims 1
- OIBDWDFYLRGLNQ-UHFFFAOYSA-N ethyl 4-[(4-butanoylphenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)CCC)=CC=C1NC(=O)NC1=CC=C(C(=O)OCC)C=C1 OIBDWDFYLRGLNQ-UHFFFAOYSA-N 0.000 claims 1
- DOZVXMMXOZVXMD-UHFFFAOYSA-N ethyl 4-[(4-butoxycarbonylphenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCCCC)=CC=C1NC(=O)NC1=CC=C(C(=O)OCC)C=C1 DOZVXMMXOZVXMD-UHFFFAOYSA-N 0.000 claims 1
- XQMAQFNMWHCRPQ-UHFFFAOYSA-N ethyl 4-[(4-chlorophenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(Cl)C=C1 XQMAQFNMWHCRPQ-UHFFFAOYSA-N 0.000 claims 1
- AHDLDMGQJFXSBH-UHFFFAOYSA-N ethyl 4-[(4-ethoxycarbonylphenyl)carbamoylamino]-2-methoxybenzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(C(=O)OCC)C(OC)=C1 AHDLDMGQJFXSBH-UHFFFAOYSA-N 0.000 claims 1
- KOAKPJSGWYVHGH-UHFFFAOYSA-N ethyl 4-[(4-ethoxycarbonylphenyl)carbamoylamino]-3-methoxybenzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(C(=O)OCC)C=C1OC KOAKPJSGWYVHGH-UHFFFAOYSA-N 0.000 claims 1
- KPCPWCOJCNAPSX-UHFFFAOYSA-N ethyl 4-[(4-fluoro-2-methylphenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(F)C=C1C KPCPWCOJCNAPSX-UHFFFAOYSA-N 0.000 claims 1
- GNMDKUSDCVGCCS-UHFFFAOYSA-N ethyl 4-[(4-fluoro-3-methoxyphenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(F)C(OC)=C1 GNMDKUSDCVGCCS-UHFFFAOYSA-N 0.000 claims 1
- GIOJOZUVJQCQBM-UHFFFAOYSA-N ethyl 4-[(4-fluoro-3-methylphenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(F)C(C)=C1 GIOJOZUVJQCQBM-UHFFFAOYSA-N 0.000 claims 1
- AGAHKRHRDYFBAH-UHFFFAOYSA-N ethyl 4-[(4-fluorophenyl)carbamoylamino]-3-hydroxybenzoate Chemical compound OC1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(F)C=C1 AGAHKRHRDYFBAH-UHFFFAOYSA-N 0.000 claims 1
- NVFZNTUOXHQSPO-UHFFFAOYSA-N ethyl 4-[(4-fluorophenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(F)C=C1 NVFZNTUOXHQSPO-UHFFFAOYSA-N 0.000 claims 1
- TYHPBHLAXUWVDL-UHFFFAOYSA-N ethyl 4-[(4-imidazol-1-ylphenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(N2C=NC=C2)C=C1 TYHPBHLAXUWVDL-UHFFFAOYSA-N 0.000 claims 1
- AJHBMLNHWSRQNL-UHFFFAOYSA-N ethyl 4-[(4-methylsulfanylphenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(SC)C=C1 AJHBMLNHWSRQNL-UHFFFAOYSA-N 0.000 claims 1
- GZWOVIZUQZEDGL-UHFFFAOYSA-N ethyl 4-[(4-pentoxycarbonylphenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCCCCC)=CC=C1NC(=O)NC1=CC=C(C(=O)OCC)C=C1 GZWOVIZUQZEDGL-UHFFFAOYSA-N 0.000 claims 1
- CCHPQPXIPIEUPY-UHFFFAOYSA-N ethyl 4-[(4-phenoxycarbonylphenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(C(=O)OC=2C=CC=CC=2)C=C1 CCHPQPXIPIEUPY-UHFFFAOYSA-N 0.000 claims 1
- AJWWIQMPRRKLKN-UHFFFAOYSA-N ethyl 4-[(4-propanoylphenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(C(=O)CC)C=C1 AJWWIQMPRRKLKN-UHFFFAOYSA-N 0.000 claims 1
- DPDQWRGMCIXKBB-UHFFFAOYSA-N ethyl 4-[(4-propoxycarbonylphenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCCC)=CC=C1NC(=O)NC1=CC=C(C(=O)OCC)C=C1 DPDQWRGMCIXKBB-UHFFFAOYSA-N 0.000 claims 1
- SAIUAYATIGVZCO-UHFFFAOYSA-N ethyl 4-[(6-chloropyridin-3-yl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(Cl)N=C1 SAIUAYATIGVZCO-UHFFFAOYSA-N 0.000 claims 1
- GVYUYGGJBOPNPO-UHFFFAOYSA-N ethyl 4-[(6-fluoro-1,3-benzothiazol-2-yl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=NC2=CC=C(F)C=C2S1 GVYUYGGJBOPNPO-UHFFFAOYSA-N 0.000 claims 1
- DXBGGXIHUWFGQI-UHFFFAOYSA-N ethyl 4-[(6-methoxypyridin-3-yl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(OC)N=C1 DXBGGXIHUWFGQI-UHFFFAOYSA-N 0.000 claims 1
- SNVIHCGKYVDOFN-UHFFFAOYSA-N ethyl 4-[(6-morpholin-4-ylpyridin-3-yl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(N2CCOCC2)N=C1 SNVIHCGKYVDOFN-UHFFFAOYSA-N 0.000 claims 1
- IRENAQZVUJHUAH-UHFFFAOYSA-N ethyl 4-[2-(1-methylpyrrol-2-yl)ethylcarbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NCCC1=CC=CN1C IRENAQZVUJHUAH-UHFFFAOYSA-N 0.000 claims 1
- QUOJIWNRBBUPRU-UHFFFAOYSA-N ethyl 4-[[3-(1,3-oxazol-5-yl)phenyl]carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=CC(C=2OC=NC=2)=C1 QUOJIWNRBBUPRU-UHFFFAOYSA-N 0.000 claims 1
- LHNLQNCBECZTDA-UHFFFAOYSA-N ethyl 4-[[3-(2-methylpyrimidin-4-yl)phenyl]carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=CC(C=2N=C(C)N=CC=2)=C1 LHNLQNCBECZTDA-UHFFFAOYSA-N 0.000 claims 1
- HBBKGFIWFLKKLU-UHFFFAOYSA-N ethyl 4-[[4-(1,1,2,2-tetrafluoroethoxy)phenyl]carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(OC(F)(F)C(F)F)C=C1 HBBKGFIWFLKKLU-UHFFFAOYSA-N 0.000 claims 1
- DHLBHBAONQVVCR-UHFFFAOYSA-N ethyl 4-[[4-(1,3-oxazol-5-yl)phenyl]carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(C=2OC=NC=2)C=C1 DHLBHBAONQVVCR-UHFFFAOYSA-N 0.000 claims 1
- GFFFUDJOHZOVMJ-UHFFFAOYSA-N ethyl 4-[[4-(1h-pyrazol-5-yl)phenyl]carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(C2=NNC=C2)C=C1 GFFFUDJOHZOVMJ-UHFFFAOYSA-N 0.000 claims 1
- OSWPKSIANACMJB-UHFFFAOYSA-N ethyl 4-[[4-(2-ethoxy-2-oxoethyl)phenyl]carbamoylamino]benzoate Chemical compound C1=CC(CC(=O)OCC)=CC=C1NC(=O)NC1=CC=C(C(=O)OCC)C=C1 OSWPKSIANACMJB-UHFFFAOYSA-N 0.000 claims 1
- FAQDLJBNGDFYMA-UHFFFAOYSA-N ethyl 4-[[4-(2-methylpropoxycarbonyl)phenyl]carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(C(=O)OCC(C)C)C=C1 FAQDLJBNGDFYMA-UHFFFAOYSA-N 0.000 claims 1
- FPFQEESCIWMZKS-UHFFFAOYSA-N ethyl 4-[[4-(2-methylpyrimidin-4-yl)phenyl]carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(C=2N=C(C)N=CC=2)C=C1 FPFQEESCIWMZKS-UHFFFAOYSA-N 0.000 claims 1
- JKLQCJYMCQGKRK-UHFFFAOYSA-N ethyl 4-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(C=2OCCN=2)C=C1 JKLQCJYMCQGKRK-UHFFFAOYSA-N 0.000 claims 1
- CGZPONNDMBJAHJ-UHFFFAOYSA-N ethyl 4-[[4-(thiadiazol-4-yl)phenyl]carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(C=2N=NSC=2)C=C1 CGZPONNDMBJAHJ-UHFFFAOYSA-N 0.000 claims 1
- QMCYNBAMYIZSCQ-UHFFFAOYSA-N ethyl 4-methyl-2-[(4-methylsulfanylphenyl)carbamoylamino]-1,3-thiazole-5-carboxylate Chemical compound CC1=C(C(=O)OCC)SC(NC(=O)NC=2C=CC(SC)=CC=2)=N1 QMCYNBAMYIZSCQ-UHFFFAOYSA-N 0.000 claims 1
- JMCJHSGHUSDBMI-UHFFFAOYSA-N ethyl 6-[(4-ethoxycarbonylphenyl)carbamoylamino]pyridine-3-carboxylate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(C(=O)OCC)C=N1 JMCJHSGHUSDBMI-UHFFFAOYSA-N 0.000 claims 1
- 210000001035 gastrointestinal tract Anatomy 0.000 claims 1
- 230000036543 hypotension Effects 0.000 claims 1
- 208000026278 immune system disease Diseases 0.000 claims 1
- 206010027175 memory impairment Diseases 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- NRGLZGBNZJGZKI-UHFFFAOYSA-N methyl 2-[(4-ethoxycarbonylphenyl)carbamoylamino]-1,3-thiazole-5-carboxylate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=NC=C(C(=O)OC)S1 NRGLZGBNZJGZKI-UHFFFAOYSA-N 0.000 claims 1
- BVSQCSILUMBZQS-UHFFFAOYSA-N methyl 2-[(4-ethoxycarbonylphenyl)carbamoylamino]thiophene-3-carboxylate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=C(C(=O)OC)C=CS1 BVSQCSILUMBZQS-UHFFFAOYSA-N 0.000 claims 1
- ILZREKGNTSOUAX-UHFFFAOYSA-N methyl 3-[(4-ethoxycarbonylphenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=CC(C(=O)OC)=C1 ILZREKGNTSOUAX-UHFFFAOYSA-N 0.000 claims 1
- PFWFFNFPPYAMLK-UHFFFAOYSA-N methyl 4-[(4-fluorophenyl)carbamoylamino]-3-hydroxybenzoate Chemical compound OC1=CC(C(=O)OC)=CC=C1NC(=O)NC1=CC=C(F)C=C1 PFWFFNFPPYAMLK-UHFFFAOYSA-N 0.000 claims 1
- JMOUJOMNIUZYGP-UHFFFAOYSA-N methyl 4-[(4-fluorophenyl)carbamoylamino]-3-methylbenzoate Chemical compound CC1=CC(C(=O)OC)=CC=C1NC(=O)NC1=CC=C(F)C=C1 JMOUJOMNIUZYGP-UHFFFAOYSA-N 0.000 claims 1
- GXWOZLUDXOONHR-UHFFFAOYSA-N methyl 4-[(4-fluorophenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1NC(=O)NC1=CC=C(F)C=C1 GXWOZLUDXOONHR-UHFFFAOYSA-N 0.000 claims 1
- OUYGAKBMUFDONT-UHFFFAOYSA-N methyl 5-[(4-ethoxycarbonylphenyl)carbamoylamino]furan-2-carboxylate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(C(=O)OC)O1 OUYGAKBMUFDONT-UHFFFAOYSA-N 0.000 claims 1
- LURCDYPZSKUGII-UHFFFAOYSA-N methyl 6-[(4-ethoxycarbonylphenyl)carbamoylamino]pyridine-3-carboxylate Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=O)NC1=CC=C(C(=O)OC)C=N1 LURCDYPZSKUGII-UHFFFAOYSA-N 0.000 claims 1
- RYTXFKPJABIZJS-UHFFFAOYSA-N methyl 6-[(4-fluorophenyl)carbamoylamino]pyridine-3-carboxylate Chemical compound N1=CC(C(=O)OC)=CC=C1NC(=O)NC1=CC=C(F)C=C1 RYTXFKPJABIZJS-UHFFFAOYSA-N 0.000 claims 1
- 230000001730 monoaminergic effect Effects 0.000 claims 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 1
- 125000002950 monocyclic group Chemical group 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- 201000007620 paralytic ileus Diseases 0.000 claims 1
- VLHQFLDQFIIVQA-UHFFFAOYSA-N pentyl 4-[(4-fluorophenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCCCCC)=CC=C1NC(=O)NC1=CC=C(F)C=C1 VLHQFLDQFIIVQA-UHFFFAOYSA-N 0.000 claims 1
- 206010034674 peritonitis Diseases 0.000 claims 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 1
- YKIDTZMERLJXEY-UHFFFAOYSA-N phenyl 4-[(4-fluorophenyl)carbamoylamino]benzoate Chemical compound C1=CC(F)=CC=C1NC(=O)NC1=CC=C(C(=O)OC=2C=CC=CC=2)C=C1 YKIDTZMERLJXEY-UHFFFAOYSA-N 0.000 claims 1
- 230000002035 prolonged effect Effects 0.000 claims 1
- VYKHVKJJPHJKGC-UHFFFAOYSA-N propyl 4-[(4-fluorophenyl)carbamoylamino]benzoate Chemical compound C1=CC(C(=O)OCCC)=CC=C1NC(=O)NC1=CC=C(F)C=C1 VYKHVKJJPHJKGC-UHFFFAOYSA-N 0.000 claims 1
- 208000020016 psychiatric disease Diseases 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 230000000306 recurrent effect Effects 0.000 claims 1
- 230000001850 reproductive effect Effects 0.000 claims 1
- 208000017443 reproductive system disease Diseases 0.000 claims 1
- 230000000241 respiratory effect Effects 0.000 claims 1
- 210000002345 respiratory system Anatomy 0.000 claims 1
- 201000000980 schizophrenia Diseases 0.000 claims 1
- 230000002784 sclerotic effect Effects 0.000 claims 1
- 230000036303 septic shock Effects 0.000 claims 1
- 230000000391 smoking effect Effects 0.000 claims 1
- SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 claims 1
- 125000001113 thiadiazolyl group Chemical group 0.000 claims 1
- 125000000335 thiazolyl group Chemical group 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60226804P | 2004-08-16 | 2004-08-16 | |
| PCT/GB2005/050131 WO2006018662A2 (en) | 2004-08-16 | 2005-08-16 | Aryl urea derivatives for treating obesity |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012037806A Division JP2012140445A (ja) | 2004-08-16 | 2012-02-23 | アリール尿素誘導体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008509982A JP2008509982A (ja) | 2008-04-03 |
| JP2008509982A5 true JP2008509982A5 (cg-RX-API-DMAC7.html) | 2008-08-07 |
Family
ID=35134573
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007526578A Pending JP2008509982A (ja) | 2004-08-16 | 2005-08-16 | アリール尿素誘導体 |
| JP2012037806A Withdrawn JP2012140445A (ja) | 2004-08-16 | 2012-02-23 | アリール尿素誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012037806A Withdrawn JP2012140445A (ja) | 2004-08-16 | 2012-02-23 | アリール尿素誘導体 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20080261952A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1786422A2 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2008509982A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006018662A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1558582B1 (en) | 2003-07-22 | 2005-12-21 | Arena Pharmaceuticals, Inc. | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto |
| CA2543882A1 (en) | 2003-10-30 | 2005-05-19 | Merck & Co., Inc. | Aralkyl amines as cannabinoid receptor modulators |
| ATE548353T1 (de) | 2004-03-23 | 2012-03-15 | Arena Pharm Inc | Verfahren zur herstellung von substituierte n- aryl-n'-ä3-(1h-pyrazol-5-yl)phenylü-harnstoffe and intermediate davon. |
| EP1807390A4 (en) * | 2004-11-04 | 2008-07-02 | Neurogen Corp | ARYL ALKYL UREA AS CB1 ANTAGONISTS |
| PE20061130A1 (es) | 2004-11-19 | 2007-01-05 | Arena Pharm Inc | Derivados de 3-fenil-pirazol como moduladores del receptor de serotonina 5-ht2a |
| CA2589271A1 (en) | 2004-12-07 | 2006-06-15 | Locus Pharmaceuticals, Inc. | Urea inhibitors of map kinases |
| JP5212101B2 (ja) * | 2005-09-02 | 2013-06-19 | アステラス製薬株式会社 | 新規化合物 |
| TWI370130B (en) | 2005-11-24 | 2012-08-11 | Eisai R&D Man Co Ltd | Two cyclic cinnamide compound |
| TWI378091B (en) | 2006-03-09 | 2012-12-01 | Eisai R&D Man Co Ltd | Multi-cyclic cinnamide derivatives |
| EP2018371B1 (en) | 2006-05-18 | 2015-03-04 | Arena Pharmaceuticals, Inc. | Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| CN104761498B (zh) | 2006-05-18 | 2017-12-26 | 艾尼纳制药公司 | 5‑ht2a血清素受体的调节剂 |
| WO2007136689A2 (en) | 2006-05-18 | 2007-11-29 | Arena Pharmaceuticals, Inc. | Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor |
| EP2019093A4 (en) * | 2006-05-19 | 2011-02-23 | Eisai R&D Man Co Ltd | CINEMA ACID AMID DERIVATIVE FROM THE UREA TYPE |
| EP2046329A2 (en) * | 2006-08-01 | 2009-04-15 | Arete Therapeutics, INC. | Soluble epoxide hydrolase inhibitors |
| JP2010504362A (ja) * | 2006-09-25 | 2010-02-12 | アレテ セラピューティクス， インコーポレイテッド | 可溶性エポキシドヒドロラーゼ阻害剤 |
| TWI415845B (zh) | 2006-10-03 | 2013-11-21 | Arena Pharm Inc | 用於治療與５-ｈｔ2ａ血清素受體相關聯病症之作為５-ｈｔ2ａ血清素受體之調節劑的吡唑衍生物 |
| FR2908409B1 (fr) * | 2006-11-10 | 2009-01-09 | Sanofi Aventis Sa | Pyrazoles substituees,compositions les contenant,procede de fabrication et utilisation |
| TW200848054A (en) | 2007-02-28 | 2008-12-16 | Eisai R&D Man Co Ltd | Two cyclic oxomorpholine derivatives |
| US9567327B2 (en) | 2007-08-15 | 2017-02-14 | Arena Pharmaceuticals, Inc. | Imidazo[1,2-a]pyridine derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto |
| EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| US7935815B2 (en) | 2007-08-31 | 2011-05-03 | Eisai R&D Management Co., Ltd. | Imidazoyl pyridine compounds and salts thereof |
| CA2694401C (en) | 2007-08-31 | 2012-12-04 | Eisai R&D Management Co., Ltd. | Polycyclic compound |
| WO2009035951A2 (en) * | 2007-09-11 | 2009-03-19 | Arete Therapeutics, Inc. | Soluble epoxide hydrolase inhibitors |
| WO2009035949A2 (en) * | 2007-09-13 | 2009-03-19 | Arete Therapeutics, Inc. | Soluble epoxide hydrolase inhibitors |
| WO2009123714A2 (en) | 2008-04-02 | 2009-10-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| JPWO2010018856A1 (ja) * | 2008-08-13 | 2012-01-26 | 持田製薬株式会社 | カンナビノイド受容体関連疾患の予防／改善または治療剤 |
| WO2010019930A1 (en) * | 2008-08-15 | 2010-02-18 | Locus Pharmaceuticals, Inc. | Urea derivatives as inhibitors of map kinases |
| US9126946B2 (en) | 2008-10-28 | 2015-09-08 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto |
| NO2364142T3 (cg-RX-API-DMAC7.html) | 2008-10-28 | 2018-06-16 | ||
| WO2011062955A2 (en) | 2009-11-18 | 2011-05-26 | University Of Massachusetts | Compounds for modulating tlr2 |
| US8980891B2 (en) | 2009-12-18 | 2015-03-17 | Arena Pharmaceuticals, Inc. | Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto |
| US9452980B2 (en) | 2009-12-22 | 2016-09-27 | Hoffmann-La Roche Inc. | Substituted benzamides |
| US8933024B2 (en) | 2010-06-18 | 2015-01-13 | Sanofi | Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
| US8697739B2 (en) * | 2010-07-29 | 2014-04-15 | Novartis Ag | Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof |
| BRPI1004176A2 (pt) * | 2010-10-25 | 2015-08-11 | Univ Rio De Janeiro | Compostos aril e/ou hetero aril uréias funcionalizados; processo de síntese desses composto; composição farmacêutica contendo tais compostos e usos |
| EP2683699B1 (de) | 2011-03-08 | 2015-06-24 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| US8828995B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| EP2683700B1 (de) | 2011-03-08 | 2015-02-18 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| EP2766349B1 (de) | 2011-03-08 | 2016-06-01 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| US8461179B1 (en) | 2012-06-07 | 2013-06-11 | Deciphera Pharmaceuticals, Llc | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases |
| ES2489297B1 (es) * | 2013-01-22 | 2015-06-10 | Consejo Superior De Investigaciones Científicas (Csic) | Benzotiazoles sustituidos y sus aplicaciones terapeuticas para el tratamiento de enfermedades humanas |
| US9926275B2 (en) * | 2013-08-22 | 2018-03-27 | Northeastern University | Allosteric modulators of the cannabinoid 1 receptor |
| GB201401886D0 (en) | 2014-02-04 | 2014-03-19 | Lytix Biopharma As | Neurodegenerative therapies |
| WO2015162216A1 (en) * | 2014-04-24 | 2015-10-29 | Universita' Degli Studi Di Siena | Biaryl amide or urea derivatives as trpv1 ligands |
| CZ305633B6 (cs) * | 2014-08-13 | 2016-01-13 | Univerzita Hradec Králové | Deriváty benzothiazolylmočoviny, způsob jejich přípravy a jejich použití |
| CA2998647A1 (en) * | 2014-10-03 | 2016-04-07 | The Royal Institution For The Advancement Of Learning/Mcgill University | Urea and bis-urea based compounds and analogues thereof useful in the treatment of androgen receptor mediated diseases or disorders |
| CN109562085A (zh) | 2015-06-12 | 2019-04-02 | 阿速万科学有限责任公司 | 用于预防和治疗rem睡眠行为障碍的二芳基和芳基杂芳基脲衍生物 |
| KR20180064373A (ko) | 2015-07-15 | 2018-06-14 | 엑소반트 사이언시즈 게엠베하 | 신경퇴행성 질환과 관련된 환각의 예방 및 치료에 유용한 5-ht2a 세로토닌 수용체의 조절자로서의 다이아릴 및 아릴헤테로아릴 우레아 유도체 |
| WO2017152117A1 (en) | 2016-03-03 | 2017-09-08 | Cornell University | Small molecule ire1-alpha inhibitors |
| CA3013696C (en) | 2016-03-17 | 2024-04-16 | F. Hoffmann-La Roche Ag | 5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of taar |
| WO2018209030A1 (en) * | 2017-05-12 | 2018-11-15 | Rti International | Diarylureas as cb1 allosteric modulators |
| EP3746059A1 (en) | 2018-01-31 | 2020-12-09 | Deciphera Pharmaceuticals, LLC | Combination therapy for the treatment of gastrointestinal stromal tumors |
| MX2020008015A (es) | 2018-01-31 | 2020-10-16 | Deciphera Pharmaceuticals Llc | Terapia de combinación para el tratamiento de la mastocitosis. |
| WO2020126968A2 (en) * | 2018-12-20 | 2020-06-25 | Bayer Aktiengesellschaft | Urea derivatives |
| CA3140660A1 (en) * | 2019-06-28 | 2020-12-30 | Yanan Zhang | Urea derivatives as cb1 allosteric modulators |
| TWI878335B (zh) | 2019-08-12 | 2025-04-01 | 美商迪賽孚爾製藥有限公司 | 治療胃腸道基質瘤方法 |
| NZ784949A (en) | 2019-08-12 | 2025-09-26 | Deciphera Pharmaceuticals Llc | Ripretinib for treating gastrointestinal stromal tumors |
| MX2022008103A (es) | 2019-12-30 | 2022-09-19 | Deciphera Pharmaceuticals Llc | Formulaciones de inhibidores de la cinasa amorfa y metodos de estas. |
| KR20250057151A (ko) | 2019-12-30 | 2025-04-28 | 데시페라 파마슈티칼스, 엘엘씨 | 1-(4-브로모-5-(1-에틸-7-(메틸아미노)-2-옥소-1,2-디히드로-1,6-나프티리딘-3-일)-2-플루오로페닐)-3-페닐우레아의조성물 |
| WO2021222637A1 (en) * | 2020-04-30 | 2021-11-04 | United States Government As Represented By The Department Of Veterans Affairs | Krüppel-like factor 15 (klf15) small molecule agonists in kidney disease |
| US11779572B1 (en) | 2022-09-02 | 2023-10-10 | Deciphera Pharmaceuticals, Llc | Methods of treating gastrointestinal stromal tumors |
| WO2024246857A1 (en) * | 2023-06-02 | 2024-12-05 | Innopharmascreen Inc. | Urea compounds, compositions, and methods for treating asthma and parkinson's disease |
| WO2025085745A1 (en) | 2023-10-18 | 2025-04-24 | Gen1E Lifesciences Inc. | Modulators of extracellular signal-regulated kinase |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4088768A (en) * | 1975-05-06 | 1978-05-09 | Eli Lilly And Company | N-heterocyclic ureas as immune regulants |
| DK41193D0 (da) * | 1993-04-07 | 1993-04-07 | Neurosearch As | Ionkanalaabnere |
| AU2003226929A1 (en) * | 2002-11-25 | 2004-06-18 | 7Tm Pharma A/S | Novel benzamide compounds for use in mch receptor related disorders |
| WO2006049941A2 (en) * | 2004-10-27 | 2006-05-11 | Neurogen Corporation | Diaryl ureas as cb1 antagonists |
-
2005
- 2005-08-16 US US11/660,405 patent/US20080261952A1/en not_active Abandoned
- 2005-08-16 JP JP2007526578A patent/JP2008509982A/ja active Pending
- 2005-08-16 EP EP05772020A patent/EP1786422A2/en not_active Withdrawn
- 2005-08-16 WO PCT/GB2005/050131 patent/WO2006018662A2/en not_active Ceased
-
2012
- 2012-02-17 US US13/399,517 patent/US20120214808A1/en not_active Abandoned
- 2012-02-23 JP JP2012037806A patent/JP2012140445A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008509982A5 (cg-RX-API-DMAC7.html) | ||
| RU2348625C2 (ru) | Энантиомеры производных тиофенгидроксамовой кислоты и их применение в качестве ингибиторов гдац | |
| RU2454405C2 (ru) | Производные 3-пиридинкарбоксамида и 2-пиразинкарбоксамида в качестве агентов, повышающих уровень лвп-холестерина | |
| US20080261952A1 (en) | Aryl Urea Derivatives for Treating Obesity | |
| JP2013506637A5 (cg-RX-API-DMAC7.html) | ||
| RU2205827C2 (ru) | Производное ацилпиперазинилпиримидина, способы его получения, фармацевтическая композиция | |
| JP2007519695A5 (cg-RX-API-DMAC7.html) | ||
| JP5015586B2 (ja) | Ｅｐ４受容体アンタゴニスト | |
| JP2005527625A5 (cg-RX-API-DMAC7.html) | ||
| JP2009520686A5 (cg-RX-API-DMAC7.html) | ||
| JP2006503019A5 (cg-RX-API-DMAC7.html) | ||
| JP2006525298A5 (cg-RX-API-DMAC7.html) | ||
| CA2150300A1 (en) | Amino-benzofuryl- and thienyl-derivatives | |
| RU2007117913A (ru) | 2, 6-замещенные-4-монозамещенный амино-пиримидины как антагонисты рецептора простагландина d2 | |
| RU2005137403A (ru) | Новые замещенные 3-сера-индолы | |
| RU2017139727A (ru) | Гетероциклические ингибиторы erk1 и erk2 и их применение для лечения злокачественного новообразования | |
| JP2009525960A5 (cg-RX-API-DMAC7.html) | ||
| RU2009102770A (ru) | Производные бензимидазола, методы их получения, применение их в качестве агонистов фарнезоид-х-рецептора (fxr) и содержащие их фармацевтические препараты | |
| CA2454703A1 (en) | Novel thiophene carboxamide derivatives | |
| JP2006507241A5 (cg-RX-API-DMAC7.html) | ||
| RU2006117635A (ru) | Производные индолинона и их применение для лечения патологических состояний, таких как злокачественное новообразование | |
| CN1124488A (zh) | 新的噻唑烷二酮及含有这些化合物的药剂 | |
| RU2007140737A (ru) | Пиразолы | |
| RU2007114125A (ru) | Замещенные гидантоины для лечения рака | |
| WO2005026127A1 (ja) | プラスミノゲンアクチベータインヒビター－１阻害剤 |